Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Apimostinel (NRX-1074; AGN-241660) is a partial agonist of NMDA receptor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,490.00 | |
50 mg | 6-8 weeks | $ 1,940.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | Apimostinel (NRX-1074; AGN-241660) is a partial agonist of NMDA receptor. |
In vitro | Apimostinel (NRX-1074) modulates the NMDA receptor in a similar fashion to GLYX-13. Apimostinel (NRX-1074) has a synthetic modification to one of the amino acids, conferring increased potency and oral bioavailability[1]. |
In vivo | In preclinical models, both compounds demonstrate high efficacy in treating various CNS disorders[1]. |
Synonyms | AGN-241660, NRX-1074 |
Molecular Weight | 503.59 |
Formula | C25H37N5O6 |
CAS No. | 1421866-48-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 155 mg/mL (307.79 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Apimostinel 1421866-48-9 Others AGN-241660 AGN241660 AGN 241660 NRX 1074 NRX1074 NRX-1074 inhibitor inhibit